It is the study done in spinal surgeries after completion of surgery. It is to assess the pain and sedation in post operative period for 24 hours .the study is to compare between two drugs
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: 8- Other Procedures
- Registration Number
- CTRI/2022/07/044302
- Lead Sponsor
- nil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with American Society Of Anaesthesiologists Grade 1 and 2
patients with normal pulmonary function tests
patients undergoing spine surgeries
Exclusion Criteria
patients with American Society Of Anaesthesiologists 3 and 4
patients on any opoids or any sedative medication in the week prior to the surgery
patients with history of alcohol or drug abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) vitals in post operative period <br/ ><br>2) scoring of pain <br/ ><br>3) sedation score <br/ ><br>4) Any side effects in post operative periodTimepoint: From time of completion of surgical procedure till 24hours postoperatively
- Secondary Outcome Measures
Name Time Method 1) Any side effects in post operative period in spine surgeries <br/ ><br>Nausea, vomitingTimepoint: till 24 hours postoperatively
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which Dexmeditomidine enhances opioid-sparing effects in post-spinal surgery analgesia?
How does the combination of Dexmeditomidine and Fentanyl compare to Fentanyl alone in managing postoperative pain in spinal surgeries?
Are there specific biomarkers that can predict patient response to Dexmeditomidine-based analgesic regimens in spinal surgery recovery?
What are the potential adverse events associated with Dexmeditomidine infusion in the postoperative period of spinal surgeries?
What are the current trends in adjuvant analgesic strategies for spinal surgery, and how does this trial contribute to the field?